114 related articles for article (PubMed ID: 16951211)
1. Aurora sheds light on head and neck squamous cell carcinoma.
Han H; Von Hoff DD
Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
[No Abstract] [Full Text] [Related]
2. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma.
Reiter R; Gais P; Jütting U; Steuer-Vogt MK; Pickhard A; Bink K; Rauser S; Lassmann S; Höfler H; Werner M; Walch A
Clin Cancer Res; 2006 Sep; 12(17):5136-41. PubMed ID: 16951231
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarkers in head and neck cancer.
Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5005-6. PubMed ID: 16951212
[No Abstract] [Full Text] [Related]
4. Is gene expression profiling of head and neck cancers ready for the clinic?
Ziober AF; D'Alessandro L; Ziober BL
Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
[TBL] [Abstract][Full Text] [Related]
6. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
7. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
8. Role of molecular markers in the management of head and neck cancers.
Ferreira MB; De Souza JA; Cohen EE
Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
Le QT; Giaccia AJ
Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
[TBL] [Abstract][Full Text] [Related]
10. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
Haffty BG
Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
[No Abstract] [Full Text] [Related]
11. Head and neck cancer: reduce and integrate for optimal outcome.
Belbin TJ; Bergman A; Brandwein-Gensler M; Chen Q; Childs G; Garg M; Haigentz M; Hogue-Angeletti R; Moadel R; Negassa A; Owen R; Prystowsky MB; Schiff B; Schlecht NF; Shifteh K; Smith RV; Zheng X
Cytogenet Genome Res; 2007; 118(2-4):92-109. PubMed ID: 18000360
[No Abstract] [Full Text] [Related]
12. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
13. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
14. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
15. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
Cohen EE
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
[No Abstract] [Full Text] [Related]
16. [Genetic mutation in head and neck squamous cell carcinoma].
Shiga K
Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1059-64. PubMed ID: 12549511
[No Abstract] [Full Text] [Related]
17. Genetic factors associated with head and neck cancer.
Br Dent J; 2007 Jan; 202(2):58. PubMed ID: 17255975
[No Abstract] [Full Text] [Related]
18. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for head and neck cancer].
Fujieda S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
[TBL] [Abstract][Full Text] [Related]
20. Correlation of biomarkers in head and neck squamous cell carcinoma.
Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
